Ian Gleeson1. 1. Department of Medical Physics, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Abstract
AIM: To compare the radiotherapy technique used in a randomised trial with VMAT and an in-house technique for prostate cancer. BACKGROUND: Techniques are evolving with volumetric modulated arc therapy (VMAT) commonly used. The CHHiP trial used a 3 PTV forward planned IMRT technique (FP_CH). Our centre has adopted a simpler two PTV technique with locally calculated margins. MATERIALS AND METHODS: 25 patients treated with FP_CH to 60 Gy in 20 fractions were re-planned with VMAT (VMAT_CH) and a two PTV protocol (VMAT_60/52 and VMAT_60/48). Target coverage, conformity index (CI), homogeneity index (HI), monitor units (MU) and dose to the rectum, bladder, hips and penile bulb were compared. RESULTS: PTV coverage was high for all techniques. VMAT_CH plans had better CI than FP_CH (p ≤ 0.05). VMAT_60/52/48 plans had better CI than VMAT_CH. FP_CH had better HI and fewer MU than VMAT (p ≤ 0.05). More favourable rectum doses were found for VMAT _CH than FP_CH (V48.6, V52.8, V57, p ≤ 0.05) with less difference for bladder (p ≥ 0.05). Comparing VMAT_CH to VMAT_60/52/48 showed little differences for the bladder and rectum but VMAT_CH had larger penile bulb doses (V40.8, V48.6, mean, D2, p ≤ 0.05). Femoral head doses (V40.8) were similarly low for all techniques (p = ≥ 0.05). CONCLUSION: VMAT produced more conformal plans with smaller rectum doses compared to FP_CH albeit worse HI and more MU. VMAT_60/52 and VMAT_60/48 plans had similar rectal and bladder doses to VMAT_CH but better CI and penile bulb doses which may reduce toxicity. Crown
AIM: To compare the radiotherapy technique used in a randomised trial with VMAT and an in-house technique for prostate cancer. BACKGROUND: Techniques are evolving with volumetric modulated arc therapy (VMAT) commonly used. The CHHiP trial used a 3 PTV forward planned IMRT technique (FP_CH). Our centre has adopted a simpler two PTV technique with locally calculated margins. MATERIALS AND METHODS: 25 patients treated with FP_CH to 60 Gy in 20 fractions were re-planned with VMAT (VMAT_CH) and a two PTV protocol (VMAT_60/52 and VMAT_60/48). Target coverage, conformity index (CI), homogeneity index (HI), monitor units (MU) and dose to the rectum, bladder, hips and penile bulb were compared. RESULTS: PTV coverage was high for all techniques. VMAT_CH plans had better CI than FP_CH (p ≤ 0.05). VMAT_60/52/48 plans had better CI than VMAT_CH. FP_CH had better HI and fewer MU than VMAT (p ≤ 0.05). More favourable rectum doses were found for VMAT _CH than FP_CH (V48.6, V52.8, V57, p ≤ 0.05) with less difference for bladder (p ≥ 0.05). Comparing VMAT_CH to VMAT_60/52/48 showed little differences for the bladder and rectum but VMAT_CH had larger penile bulb doses (V40.8, V48.6, mean, D2, p ≤ 0.05). Femoral head doses (V40.8) were similarly low for all techniques (p = ≥ 0.05). CONCLUSION: VMAT produced more conformal plans with smaller rectum doses compared to FP_CH albeit worse HI and more MU. VMAT_60/52 and VMAT_60/48 plans had similar rectal and bladder doses to VMAT_CH but better CI and penile bulb doses which may reduce toxicity. Crown
Authors: Larry Kestin; Neal Goldstein; Frank Vicini; Di Yan; Howard Korman; Alvaro Martinez Journal: Int J Radiat Oncol Biol Phys Date: 2002-11-01 Impact factor: 7.038
Authors: William C Jackson; Jessica Silva; Holly E Hartman; Robert T Dess; Amar U Kishan; Whitney H Beeler; Laila A Gharzai; Elizabeth M Jaworski; Rohit Mehra; Jason W D Hearn; Todd M Morgan; Simpa S Salami; Matthew R Cooperberg; Brandon A Mahal; Payal D Soni; Samuel Kaffenberger; Paul L Nguyen; Neil Desai; Felix Y Feng; Zachary S Zumsteg; Daniel E Spratt Journal: Int J Radiat Oncol Biol Phys Date: 2019-04-06 Impact factor: 7.038
Authors: O F Naismith; C Griffin; I Syndikus; C South; H Mayles; P Mayles; V Khoo; C Scrase; J Graham; S Hassan; E Hall; D P Dearnaley Journal: Clin Oncol (R Coll Radiol) Date: 2019-06-06 Impact factor: 4.126
Authors: Simon J Thomas; Mark Ashburner; George Samuel J Tudor; Jo Treeby; June Dean; Donna Routsis; Yvonne L Rimmer; Simon G Russell; Neil G Burnet Journal: Radiother Oncol Date: 2013-10-12 Impact factor: 6.280
Authors: Douglas H Brand; Alison C Tree; Peter Ostler; Hans van der Voet; Andrew Loblaw; William Chu; Daniel Ford; Shaun Tolan; Suneil Jain; Alexander Martin; John Staffurth; Philip Camilleri; Kiran Kancherla; John Frew; Andrew Chan; Ian S Dayes; Daniel Henderson; Stephanie Brown; Clare Cruickshank; Stephanie Burnett; Aileen Duffton; Clare Griffin; Victoria Hinder; Kirsty Morrison; Olivia Naismith; Emma Hall; Nicholas van As Journal: Lancet Oncol Date: 2019-09-17 Impact factor: 41.316
Authors: Dorota Maria Borowicz; Konstantin N Shipulin; Gennady V Mytsin; Agnieszka Skrobała; Piotr Milecki; Victor N Gayevsky; Vladimir Vondráček; Julian Malicki Journal: J Pers Med Date: 2021-12-06